Heart failure with preserved ejection fraction (HFpEF) affects half of all patients with heart
failure worldwide, is increasing in prevalence, confers substantial morbidity and mortality …

Heart failure with preserved ejection fraction (HFpEF) is a condition with increasing
incidence, leading to a health care problem of epidemic proportions for which no curative …

Heart failure (HF) is a clinical syndrome characterized by typical symptoms and signs
caused by a structural and/or functional cardiac abnormality, resulting in a reduced cardiac …

Heart failure with preserved ejection fraction (HFpEF) is one of the most complex and most
prevalent cardiometabolic diseases in aging population. Age, obesity, diabetes, and …

Background Recent heart failure (HF) guidelines have re‐classified HF patients with left
ventricular ejection fraction (LVEF) between 41% and 49% as HF with mildly reduced …

HFpEF represents a heterogeneous syndrome with complex pathophysiological substrates
and multiple clinical manifestations. Recently, much attention has been focused on cardiac …

Introduction Heart failure (HF) is a serious complication of end-stage kidney disease
(ESKD). However, most data come from retrospective studies that included patients on …

Background: Left ventricular contractile reserve (LVCR), coronary flow velocity reserve
(CFVR), and heart rate reserve (HRR) affect outcome in heart failure (HF). They can be …

Heart failure with preserved ejection fraction (HFpEF) is a common public health problem
associated with increased morbidity and long-term mortality. However, effective treatment for …

Heart failure with preserved ejection fraction (HFpEF) currently accounts for over 50% of all
heart failure cases. It displays a large number of comorbidities, and the pathophysiological …